Effects of an antioxidant beverage on biomarkers of oxidative stress in Alzheimer’s patients

European Journal of Nutrition

Volumn 55, Issue 6, 2016, Pages 2105-2116

  Rubio Perez, Jose M ^a   Albaladejo, Maria D ^b   Zafrilla, Pilar ^a   Vidal Guevara, Maria L ^c   Morillas Ruiz, Juana M ^a  

^a CATHOLIC UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO SANTA LUCÍA   (Spain)

^c Hero Espana SA   (Spain)

Author keywords

Alzheimer s disease; Antioxidant; Apple; Beverage; Green tea; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; BILIRUBIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBONYL DERIVATIVE; CREATININE; CYANOCOBALAMIN; FERRITIN; FOLIC ACID; GLUCOSE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; IMMUNOGLOBULIN G; ISOPROSTANE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; PLACEBO; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UREA; URIC ACID; 8-OXO-7-HYDRODEOXYGUANOSINE; DEOXYGUANOSINE; LIPID; PLANT EXTRACT; TEA;

AGED; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; AMINO ACID URINE LEVEL; AMINOTRANSFERASE BLOOD LEVEL; APPLE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BEVERAGE; BILIRUBIN BLOOD LEVEL; BLOOD LEVEL; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DOUBLE BLIND PROCEDURE; DRINKING; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; ERYTHROCYTE URINE LEVEL; FEMALE; FERRITIN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; HUMAN; IN VITRO STUDY; LIPID OXIDATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; TEA; THERAPY EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; ULTRAVIOLET SPECTROPHOTOMETRY; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL; URINE LEVEL; URINE SAMPLING; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANALYSIS; BLOOD; BODY MASS; CASE CONTROL STUDY; CHEMISTRY; DRUG EFFECTS; MALUS; METABOLISM; PROTEIN CARBONYLATION; URINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ALZHEIMER DISEASE; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; BEVERAGES; BIOMARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DEOXYGUANOSINE; FEMALE; FERRITINS; FOLIC ACID; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; HUMANS; ISOPROSTANES; LIPIDS; MALE; MALUS; OXIDATIVE STRESS; PLANT EXTRACTS; PROTEIN CARBONYLATION; SUPEROXIDE DISMUTASE; TEA; VITAMIN B 12;

EID: 84939832637     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-015-1024-9     Document Type: Article

References (57)

1. World Health Organization, Alzheimer’s Disease International (2012) Dementia: a public health priority. Switzerland, Geneva
2. Feng Y, Wang X (2012) Antioxidant therapies for Alzheimer’s disease. Oxid Med Cell Longev 2012:472932. doi:10.1155/2012/472932
3. Mao P, Reddy PH (2011) Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer’s disease: implications for early intervention and therapeutics. Biochim Biophys Acta 1812 11:1359–1370. doi:10.1016/j.bbadis.2011.08.005
4. Walsh DM, Selkoe DJ (2007) A beta oligomers—a decade of discovery. J Neurochem 101(5):1172–1184
5. Dasuri K, Zhang L, Keller JN (2013) Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic Biol Med 62:170–185. doi:10.1016/j.freeradbiomed.2012.09.016
6. Sies H (1997) Oxidative stress: oxidants and antioxidants. Exp Physiol 82(2):291–295
7. Jomova K, Vondrakova D, Lawson M, Valko M (2010) Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 345(1–2):91–104. doi:10.1007/s11010-010-0563-x
8. Gabbita SP, Lovell MA, Markesbery WR (1998) Increased nuclear DNA oxidation in the brain in Alzheimer’s disease. J Neurochem 71(5):2034–2040
9. Mecocci P, MacGarvey U, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease. Ann Neurol 36(5):747–751. doi:10.1002/ana.410360510
10. Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba S, Smith MA (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer’s disease. J Neurosci 19(6):1959–1964
11. Lovell MA, Ehmann WD, Butler SM, Markesbery WR (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer’s disease. Neurology 45(8):1594–1601
12. Praticò D, Sung S (2004) Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer’s disease. J Alzheimers Dis 6(2):171–175
13. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A, Perry EK, Potocnik F, Prince M, Stewart R, Wimo A, Zhang ZX, Antuono P (2008) Alzheimer’s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 7(9):812–826. doi:10.1016/S1474-4422(08)70169-8
14. Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA (2006) Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol 65(7):631–641
15. Zafrilla P, Mulero J, Xandri JM, Santo E, Caravaca G, Morillas JM (2006) Oxidative stress in Alzheimer patients in different stages of the disease. Curr Med Chem 13(9):1075–1083
16. Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA, Freedman ML (1998) Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer’s disease. Exp Neurol 150(1):40–44
17. Padurariu M, Ciobica A, Hritcu L, Stoica B, Bild W, Stefanescu C (2010) Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer’s disease. Neurosci Lett 469(1):6–10. doi:10.1016/j.neulet.2009.11.033
18. Omar RA, Chyan YJ, Andorn AC, Poeggeler B, Robakis NK, Pappolla MA (1999) Increased expression but reduced activity of antioxidant enzymes in Alzheimer’s disease. J Alzheimers Dis 1(3):139–145
19. Ramassamy C (2006) Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol 545(1):51–64
20. Nurk E, Refsum H, Drevon CA, Tell GS, Nygaard HA, Engedal K, Smith AD (2010) Cognitive performance among the elderly in relation to the intake of plant foods. The Hordaland Health Study. Br J Nutr 104(8):1190–1201. doi:10.1017/S0007114510001807
21. Polidori MC, Praticò D, Mangialasche F, Mariani E, Aust O, Anlasik T, Mang N, Pientka L, Stahl W, Sies H, Mecocci P, Nelles G (2009) High fruit and vegetable intake is positively correlated with antioxidant status and cognitive performance in healthy subjects. J Alzheimers Dis 17(4):921–927. doi:10.3233/JAD-2009-1114
22. Hughes TF, Andel R, Small BJ, Borenstein AR, Mortimer JA, Wolk A, Johansson B, Fratiglioni L, Pedersen NL, Gatz M (2010) Midlife fruit and vegetable consumption and risk of dementia in later life in Swedish twins. Am J Geriatr Psychiatry 18(5):413–420. doi:10.1097/JGP.0b013e3181c65250
23. Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS (2006) Associations of vegetable and fruit consumption with age-related cognitive change. Neurology 67(8):1370–1376
24. Bhardwaj P, Khanna D (2013) Green tea catechins: defensive role in cardiovascular disorders. Chin J Nat Med 11(4):345–353. doi:10.1016/s1875-5364(13)60051-5
25. Lecumberri E, Dupertuis YM, Miralbell R, Pichard C (2013) Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy. Clin Nutr 32(6):894–903. doi:10.1016/j.clnu.2013.03.008
26. Lim HJ, Shim SB, Jee SW, Lee SH, Lim CJ, Hong JT, Sheen YY, Hwang DY (2013) Green tea catechin leads to global improvement among Alzheimer’s disease-related phenotypes in NSE/hAPP-C105 Tg mice. J Nutr Biochem 24(7):1302–1313. doi:10.1016/j.jnutbio.2012.10.005
27. McCann MJ, Gill CI, O’Brien G, Rao JR, McRoberts WC, Hughes P, McEntee R, Rowland IR (2007) Anti-cancer properties of phenolics from apple waste on colon carcinogenesis in vitro. Food Chem Toxicol 45(7):1224–1230
28. Serra AT, Rocha J, Sepodes B, Matias AA, Feliciano RP, de Carvalho A, Bronze MR, Duarte CM, Figueira ME (2012) Evaluation of cardiovascular protective effect of different apple varieties—correlation of response with composition. Food Chem 135(4):2378–2386. doi:10.1016/j.foodchem.2012.07.067
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34(7):939–944
30. Rubio-Perez JM, Vidal-Guevara ML, Zafrilla P, Morillas-Ruiz JM (2014) A new antioxidant beverage produced with green tea and apple. Int J Food Sci Nutr 65(5):552–557. doi:10.3109/09637486.2014.893282
31. Rubio-Perez JM, Morillas-Ruiz JM (2013) Serum cytokine profile in Alzheimer’s disease patients after ingestion of an antioxidant beverage. CNS Neurol Disord Drug Targets 12(8):1233–1241
32. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70(1):158–169
33. Rice-Evans C, Miller NJ (1994) Total antioxidant status in plasma and body fluids. Methods Enzymol 234:279–293
34. Wayner DD, Burton GW, Ingold KU, Barclay LR, Locke SJ (1987) The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta 924(3):408–419
35. Morris MC, Beckett LA, Scherr PA, Hebert LE, Bennett DA, Field TS, Evans DA (1998) Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord 12(3):121–126
36. Xu Y, Zhang JJ, Xiong L, Zhang L, Sun D, Liu H (2010) Green tea polyphenols inhibit cognitive impairment induced by chronic cerebral hypoperfusion via modulating oxidative stress. J Nutr Biochem 21(8):741–748. doi:10.1016/j.jnutbio.2009.05.002
37. Zhao BL, Li XJ, He RG, Cheng SJ, Xin WJ (1989) Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys 14(2):175–185
38. Srividhya R, Jyothilakshmi V, Arulmathi K, Senthilkumaran V, Kalaiselvi P (2008) Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (−)-epigallocatechin-3-gallate. Int J Dev Neurosci 26(2):217–223. doi:10.1016/j.ijdevneu.2007.12.003
39. Raneva VG, Shimasaki H (2005) Green tea catechins decrease lipid peroxidation in plasma and organs of C57BL/6J mice fed atherogenic diet. J Oleo Sci 54(12):641–648. doi:10.5650/jos.54.641
40. Wullner U, Seyfried J, Groscurth P, Beinroth S, Winter S, Gleichmann M, Heneka M, Löschmann P, Schulz JB, Weller M, Klockgether T (1999) Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function. Brain Res 826(1):53–62
41. Vayalil PK, Elmets CA, Katiyar SK (2003) Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. Carcinogenesis 24(5):927–936
42. Kishido T, Unno K, Yoshida H, Choba D, Fukutomi R, Asahina S, Iguchi K, Oku N, Hoshino M (2007) Decline in glutathione peroxidase activity is a reason for brain senescence: consumption of green tea catechin prevents the decline in its activity and protein oxidative damage in ageing mouse brain. Biogerontology 8(4):423–430. doi:10.1007/s10522-007-9085-7
43. Levites Y, Weinreb O, Maor G, Youdim MB, Mandel S (2001) Green tea polyphenol (−)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 78(5):1073–1082
44. Chan P, Cheng JT, Tsai JC, Lien GS, Chen FC, Kao PF, Liu JC, Chen YJ, Hsieh MH (2002) Effect of catechin on the activity and gene expression of superoxide dismutase in cultured rat brain astrocytes. Neurosci Lett 328(3):281–284
45. Kasai H (1997) Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 387(3):147–163
46. Loft S, Poulsen HE (1996) Cancer risk and oxidative DNA damage in man. J Mol Med (Berl) 74(6):297–312
47. Erhola M, Toyokuni S, Okada K, Tanaka T, Hiai H, Ochi H, Uchida K, Osawa T, Nieminen MM, Alho H, Kellokumpu-Lehtinen P (1997) Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2′-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Lett 409(2):287–291
48. Hakim IA, Harris RB, Brown S, Chow HH, Wiseman S, Agarwal S, Talbot W (2003) Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. J Nutr 133(10):3303S–3309S
49. Klaunig JE, Xu Y, Han C, Kamendulis LM, Chen J, Heiser C, Gordon MS, Mohler ER 3rd (1999) The effect of tea consumption on oxidative stress in smokers and nonsmokers. Proc Soc Exp Biol Med 220(4):249–254
50. Parvez S, Tabassum H, Rehman H, Banerjee BD, Athar M, Raisuddin S (2006) Catechin prevents tamoxifen-induced oxidative stress and biochemical perturbations in mice. Toxicology 225(2–3):109–118
51. Nagasawa T, Hayashi H, Fujimaki N, Nishizawa N, Kitts DD (2000) Induction of oxidatively modified proteins in skeletal muscle by electrical stimulation and its suppression by dietary supplementation of (−)-epigallocatechin gallate. Biosci Biotechnol Biochem 64(5):1004–1010. doi:10.1271/bbb.64.1004
52. Manuel y Keenoy B, Vertommen J, De Leeuw I (1999) The effect of flavonoid treatment on the glycation and antioxidant status in Type 1 diabetic patients. Diabetes Nutr Metab 12(4):256–263
53. Sung S, Yao Y, Uryu K, Yang H, Lee VM, Trojanowski JQ, Praticò D (2004) Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer’s disease. FASEB J 18(2):323–325
54. Praticò D, Clark CM, Liun F, Rokach J, Lee VY, Trojanowski JQ (2002) Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol 59(6):972–976
55. Roberts LJ 2nd, Oates JA, Linton MF, Fazio S, Meador BP, Gross MD, Shyr Y, Morrow JD (2007) The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med 43(10):1388–1393
56. Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P (2012) Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol 69(7):836–841
57. Rice-Evans C, Miller N, Paganga G (1997) Antioxidant properties of phenolic compounds. Trends Plant Sci 2(4):152–159. doi:10.1016/S1360-1385(97)01018-2